Form D · Biotechnology
Vivaldi Biosciences Inc
New York, NY · CIK 0001398022
Offering snapshot reported Jul 7, 2010 · SEC filing
- Reported sold
- $1.97M Indefinite offering
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 2, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 7, 2010 | Initial | $1,974,546 | No comparison | 4 | SEC filing |
| Mar 24, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 20, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-144553
The offering consists of (i) up to $6,000,000 of Secured Convertible Promissory Notes and (ii) warrants to purchase preferred stock subject to a number of factors. No warrants have yet been exercised.
Source: Form D, filed Jul 7, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| N/A Bay City Capital Fund Iv Co Investment Fund, L.P. | Promoter |
| N/A Bay City Capital Fund Iv, L.P. | Promoter |
| N/A Douglass B. And Kim Given Revocable Trust, U/A/D 8/11/01 | Promoter |
| Adolfo Garcia Sastre, Ph.D. | Promoter |
| William Gerber | Director |
| Douglass Given | Director, Executive |
| Peter Johann | Director |
| Elliott Kieff, M.D. | Promoter |
| David Liebowitz | Executive, Promoter |
| Georg Nebgen | Director |
| Peter Palese, Ph.D. | Promoter |
| N/A Scheer Investment Holdings Ix Llc | Promoter |
| Vic Schmitt | Director |
| William O. Wick, Jr. | Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Bellevue Hospital Center 462 First Avenue, Bldg. A, Ste. 908
New York, NY, 10016
New York, NY, 10016